OBJECTIVES: To determine opioid-prescribing practices to the orthopaedic trauma (OT) population at one Level I trauma center. DESIGN: A retrospective study of discharge prescriptions for adult patients with OT. Prescription details, injury burden, and patient demographics were abstracted for patients from initial injury through a 2-month follow-up. SETTING: Level I trauma center. PATIENTS/PARTICIPANTS: Adult patients with OT admitted over a 30-day period (n = 110). INTERVENTION: All discharge and follow-up opioid prescriptions were recorded. MAIN OUTCOME MEASUREMENTS: Morphine milligram equivalents (MMEs) per day, number of opioid prescriptions, type/dose of medication prescribed. RESULTS: One hundred thirty-five discharge prescriptions were written for 110 patients with orthopaedic injuries during the review period. All patients received opioids at the time of discharge. The MMEs prescribed at the time of discharge was 114 mg (54-300 mg) for a mean of 7.21 days (2-36.7 days). Although patients with preinjury risk factors were prescribed discharge opioids for a similar duration (7.00 days vs. 7.30 days, P = 0.81) than those without risk factors, they were prescribed significantly more MMEs than those without (130 vs. 108, P < 0.05) and were more likely to receive extended-release and long-acting opioids than those without (42.11% vs. 21.98%). CONCLUSIONS: Pain management after OT continues to be opioid-centric despite involving a population at risk. Further focus on prescriber and patient education, risk evaluation with mitigation, guideline development, and comprehensive pain management strategies are warranted in the OT population. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVES: To determine opioid-prescribing practices to the orthopaedic trauma (OT) population at one Level I trauma center. DESIGN: A retrospective study of discharge prescriptions for adult patients with OT. Prescription details, injury burden, and patient demographics were abstracted for patients from initial injury through a 2-month follow-up. SETTING: Level I trauma center. PATIENTS/PARTICIPANTS: Adult patients with OT admitted over a 30-day period (n = 110). INTERVENTION: All discharge and follow-up opioid prescriptions were recorded. MAIN OUTCOME MEASUREMENTS: Morphine milligram equivalents (MMEs) per day, number of opioid prescriptions, type/dose of medication prescribed. RESULTS: One hundred thirty-five discharge prescriptions were written for 110 patients with orthopaedic injuries during the review period. All patients received opioids at the time of discharge. The MMEs prescribed at the time of discharge was 114 mg (54-300 mg) for a mean of 7.21 days (2-36.7 days). Although patients with preinjury risk factors were prescribed discharge opioids for a similar duration (7.00 days vs. 7.30 days, P = 0.81) than those without risk factors, they were prescribed significantly more MMEs than those without (130 vs. 108, P < 0.05) and were more likely to receive extended-release and long-acting opioids than those without (42.11% vs. 21.98%). CONCLUSIONS:Pain management after OT continues to be opioid-centric despite involving a population at risk. Further focus on prescriber and patient education, risk evaluation with mitigation, guideline development, and comprehensive pain management strategies are warranted in the OT population. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Debra B Gordon; Oscar A de Leon-Casasola; Christopher L Wu; Kathleen A Sluka; Timothy J Brennan; Roger Chou Journal: J Pain Date: 2015-12-21 Impact factor: 5.820
Authors: Joanna G Katzman; George D Comerci; Michael Landen; Larry Loring; Steven M Jenkusky; Sanjeev Arora; Summers Kalishman; Lisa Marr; Chris Camarata; Daniel Duhigg; Jennifer Dillow; Eugene Koshkin; Denise E Taylor; Cynthia M A Geppert Journal: Am J Public Health Date: 2014-06-12 Impact factor: 9.308
Authors: Erin M Johnson; William A Lanier; Ray M Merrill; Jacob Crook; Christina A Porucznik; Robert T Rolfs; Brian Sauer Journal: J Gen Intern Med Date: 2012-10-16 Impact factor: 5.128
Authors: Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner Journal: Clin J Pain Date: 2008 Jul-Aug Impact factor: 3.442
Authors: Dennis Lee; Sheyan Armaghani; Kristin R Archer; Jesse Bible; David Shau; Harrison Kay; Chi Zhang; Matthew J McGirt; Clinton Devin Journal: J Bone Joint Surg Am Date: 2014-06-04 Impact factor: 5.284
Authors: Abhiram R Bhashyam; Matthew Basilico; Michael J Weaver; Mitchel B Harris; Marilyn Heng Journal: J Orthop Trauma Date: 2019-04 Impact factor: 2.512
Authors: Nicholas A Trasolini; Ioanna K Bolia; Hyunwoo P Kang; Anthony Essilfie; Erik N Mayer; Reza Omid; Seth C Gamradt; George F Hatch; Alexander E Weber Journal: Orthop J Sports Med Date: 2020-06-23
Authors: Russell D Weisz; Alexander A Fokin; Vivian Lerner; Amy Flynt; Ines Macias-Perez; Leo Pavliv; Maggie Crawford; Ivan Puente Journal: J Orthop Trauma Date: 2020-07 Impact factor: 2.884